Topic

Miranda Schmalfuhs is an Associate Editor for Applied Clinical Trials. She can be reached at 

Articles

In this Q&A, Matt Smith, Vice President Research Site Development, Slope discusses the competition pharma companies and trial sponsors face when trying to become a sponsor of choice and build trust with sites and patients.

How to Become a Sponsor of Choice

The fear of exposure to SARS-CoV-2 in healthcare settings has deterred people from seeking care for non-COVID-19 diseases. One solution to patient care and biomedical research disruptions is implementing remote solutions for conducting research and collecting samples.

Pandemic-Proof Clinical Study Start-Up

Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.

Integration of Biomarker Validation in Oncology Trials

Distinguishing CAR-T and CPI approaches and the clinical trial challenges and complexities associated with each.

Immunomodulators and Cancer Research

A look at one company’s platform approach in enabling the engineering of T-cells to identify and destroy cancer.

Designing Cell Therapies to Target Solid Tumors

SynteractHCR and The GOG Foundation Work Together Supporting Gynecologic Oncology Research

Cancer's R&D Convergence will highlight the changing landscape for clinical trials in this therapeutic area based on the promise of the Cancer MoonShot initiative, along with new oncology immunotherapies.

Cancer's R&D Convergence

The war on cancer has seen significant strides made in the search for a cure, however, recent data suggests that the work is far from over.

Cancer Moonshot 2020: Next Generation Standard of Care for Cancer

How to meet the rigorous safety and efficacy demands critical to evaluating newer targeted cancer therapies.